ReWalk Robotics (RWLK) Prices 3.25M Unit Offering for Proceeds of ~$12.2M

October 27, 2016 9:21 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 2-week free trial to StreetInsider Premium here.

ReWalk Robotics Ltd. (Nasdaq: RWLK) announced that it has priced its underwritten public offering of 3,250,000 units at a price to the public of $3.75 per unit. Each unit consists of one ordinary share of the Company and 0.75 of a warrant to purchase one ordinary share with an exercise price of $4.75. All of the units in the offering are to be sold by ReWalk. The ordinary shares and the warrants will be immediately separable and issued separately, but will be purchased together in the offering.

Oppenheimer & Co. Inc. is acting as sole underwriter for the offering. ReWalk has granted the underwriter a 30-day option to purchase up to 487,500 units sold in the public offering on the same terms and conditions. The offering is expected to close on November 1, 2016, subject to customary closing conditions.

ReWalk intends to use the net proceeds of the offering for general corporate purposes, including supporting its ongoing sales, marketing and reimbursement efforts to grow its business and funding research and development activities focused on product development.

A shelf registration statement relating to the ordinary shares and warrants to be issued in the offering was filed with the Securities and Exchange Commission (the “SEC”) and is effective, and a preliminary prospectus supplement describing the terms of the offering has been filed with the SEC. The final terms of the offering will be disclosed in a final prospectus supplement to be filed with the SEC. Copies of the final prospectus supplement and the accompanying prospectus relating to these securities may be obtained, when available, from Oppenheimer & Co. Inc., Attention: Syndicate Prospectus Department, 85 Broad Street, 26th Floor, New York, New York 10004, by telephone at 212-667-8563, or by email at EquityProspectus@opco.com. The final prospectus supplement and the accompanying prospectus will also be available on the SEC’s website at www.sec.gov.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Corporate News, Equity Offerings

Related Entities

IPO

Add Your Comment